Neuren Pharmaceuticals Ltd. (NURPF)
16.10
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Neuren Pharmaceuticals 1 Year Total Returns (Daily) : 15.00% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 15.00% |
| September 04, 2026 | 26.37% |
| September 03, 2026 | 26.37% |
| September 02, 2026 | 26.42% |
| September 01, 2026 | 25.72% |
| August 31, 2026 | 25.72% |
| August 28, 2026 | 27.52% |
| August 27, 2026 | 48.04% |
| August 26, 2026 | 41.39% |
| August 25, 2026 | 41.39% |
| August 24, 2026 | 41.39% |
| August 21, 2026 | 41.39% |
| August 20, 2026 | 41.39% |
| August 19, 2026 | 41.39% |
| August 18, 2026 | 41.39% |
| August 17, 2026 | 31.92% |
| August 14, 2026 | 38.44% |
| August 13, 2026 | 38.44% |
| August 12, 2026 | 54.55% |
| August 11, 2026 | 54.55% |
| August 10, 2026 | 45.45% |
| August 07, 2026 | 36.36% |
| August 06, 2026 | 36.36% |
| August 05, 2026 | 22.36% |
| August 04, 2026 | 22.36% |
| Date | Value |
|---|---|
| August 03, 2026 | 22.36% |
| July 31, 2026 | 22.36% |
| July 30, 2026 | 21.37% |
| July 29, 2026 | 21.37% |
| July 28, 2026 | 21.37% |
| July 27, 2026 | 22.36% |
| July 24, 2026 | 22.36% |
| July 23, 2026 | 36.37% |
| July 22, 2026 | 33.93% |
| July 21, 2026 | 33.53% |
| July 20, 2026 | 33.53% |
| July 17, 2026 | 33.53% |
| July 16, 2026 | 33.53% |
| July 15, 2026 | 41.24% |
| July 14, 2026 | 38.76% |
| July 13, 2026 | 49.72% |
| July 10, 2026 | 49.72% |
| July 09, 2026 | 49.72% |
| July 08, 2026 | 49.72% |
| July 07, 2026 | 52.78% |
| July 06, 2026 | 52.78% |
| July 02, 2026 | 52.78% |
| July 01, 2026 | 52.78% |
| June 30, 2026 | 52.78% |
| June 29, 2026 | 5.22% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Percheron Therapeutics Ltd. | -79.13% |
| Starpharma Holdings Ltd. | 551.8% |
| Mayne Pharma Group Ltd. | -30.98% |
| Acrux Ltd. | -58.75% |
| Zelira Therapeutics Ltd. | 14.54% |